This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Nanotechnol. 2024, 15, 517–534, doi:10.3762/bjnano.15.46
Figure 1: (A) Representative image of alendronate loaded in a cholesterol-containing nanoarchaeosome (nanoARC...
Figure 2: HUVEC viability upon nanovesicle uptake. Viability upon 24 h of incubation with (A) void nanovesicl...
Figure 3: Viability of THP-1 macrophages upon 24 h of incubation with (A) void nanovesicles and (B) ALN- load...
Figure 4: Viability of THP-1 monocytes upon 30 and 180 min of incubation with 500 μg TL/mL nanovesicles with ...
Figure 5: Uptake of nanovesicles by (A) THP-1 macrophages and (B) THP-1 monocytes. Data are expressed as mean...
Figure 6: Effects of nanovesicle uptake by HUVECs on (A) plasma membrane order, (B) mitochondrial membrane po...
Figure 7: Effects of nanovesicle uptake by THP-1 macrophages on (A) plasma membrane order, (B) mitochondrial ...
Figure 8: Effect of nanovesicle uptake on matrix metalloproteinases secreted by THP-1 macrophages. Data are e...
Figure 9: Effect of nanovesicle uptake on cytokines released in the mild inflammation model: (A) apical (HUVE...
Figure 10: ROSs in (A) THP-1 macrophages and (B) FCs. Data are expressed as mean ± SD (n = 3).
Figure 11: Effect of nanovesicle uptake on cytokines released in the pronounced inflammation model: (A) apical...
Figure 12: Morphological changes induced by LPS on HUVECs. (A) Representative fluorescence confocal microscopy...
Figure 13: (A) Mild inflammation model. (B) Pronounced inflammation model.
Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30
Figure 1: A search conducted on PubMed (17 November 2023), employing the following keywords (articles make no...